Secukinumab administration by prefilled syringe maintains efficacy in moderate to severe plaque psoriasis over 100 weeks: Results of the FEATURE trial
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要